Amgen Company Profile (NASDAQ:AMGN)

Analyst Ratings

Consensus Ratings for Amgen (NASDAQ:AMGN) (?)
Ratings Breakdown: 1 Sell Rating(s), 9 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $182.90 (9.08% upside)

Analysts' Ratings History for Amgen (NASDAQ:AMGN)
Show:
DateFirmActionRatingPrice TargetActions
7/15/2016Robert W. BairdReiterated RatingNeutral$157.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2016Bank of America Corp.Reiterated RatingHold$182.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2016Jefferies GroupReiterated RatingBuy$187.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016BMO Capital MarketsReiterated RatingBuy$186.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Morgan StanleyReiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Sanford C. BernsteinInitiated CoverageMarket Perform$161.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Citigroup Inc.Initiated CoverageNeutral$165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016BTIG ResearchReiterated RatingSell$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016JPMorgan Chase & Co.Reiterated RatingNeutral$165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2016ArgusLower Price TargetBuy$202.00 -> $185.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$202.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/22/2015Nomura Holdings Inc.Reiterated RatingBuy$190.00 -> $191.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Raymond James Financial Inc.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015Deutsche Bank AGReiterated RatingBuy$195.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Barclays PLCBoost Price TargetEqual Weight$180.00 -> $185.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Amgen (NASDAQ:AMGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
7/27/2016Q216$2.74$5.58 billionListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016Q116$2.60$2.90$5.32 billion$5.53 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$2.29$2.61$5.53 billion$5.54 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315$2.38$2.72$5.32 billion$5.72 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$2.43$2.57$5.32 billion$5.37 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2015Q115$2.10$2.48$4.91 billion$5.03 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2015Q414$2.05$2.16$5.20 billion$5.33 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014Q314$2.11$2.30$4.95 billion$5.03 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$2.07$2.37$4.90 billion$5.18 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2014Q114$1.94$1.87$4.76 billion$4.52 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2014Q413$1.69$1.82$4.81 billion$5.01 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q313$1.78$1.94$4.60 billion$4.75 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$1.74$1.89$4.49 billion$4.68 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2013Q1 2013$1.84$1.96$4.37 billion$4.24 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2013Q4 2012$1.42$1.40$4.37 billion$4.42 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2012$1.47$1.67ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012$1.54$1.83ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012$1.22$1.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2011$1.29$1.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2011$1.29$1.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2011$1.29$1.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2011$1.11$1.17ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amgen (NASDAQ:AMGN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$2.48$2.84$2.61
Q2 20163$2.66$2.94$2.77
Q3 20163$2.74$3.22$2.91
Q4 20163$2.68$3.17$2.86
Q1 20171$2.82$2.82$2.82
Q2 20171$2.87$2.87$2.87
Q3 20171$2.87$2.87$2.87
Q4 20171$2.91$2.91$2.91
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Amgen (NASDAQ:AMGN)
Annual Dividend:$4.00
Dividend Yield:2.39%
Payout Ratio:42.28% (Based on Trailing 12 Months of Earnings)
35.78% (Based on Current Year Consensus EPS Estimate)
33.22% (Based on Next Year Consensus EPS Estimate)

Dividend History for Amgen (NASDAQ:AMGN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
7/22/2016quarterly$1.002.4%8/15/20168/17/20169/8/2016Tweet This Announcement  Share This Announcement on StockTwits
3/2/2016quarterly$1.002.74%5/13/20165/17/20166/8/2016Tweet This Announcement  Share This Announcement on StockTwits
12/15/2015quarterly$1.002.43%2/11/20162/16/20163/8/2016Tweet This Announcement  Share This Announcement on StockTwits
10/14/2015quarterly$0.792.07%11/12/201511/16/201512/7/2015Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015quarterly$0.791.84%8/13/20158/17/20159/8/2015Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015quarterly$0.791.98%5/12/20155/14/20156/5/2015Tweet This Announcement  Share This Announcement on StockTwits
12/17/2014quarterly$0.791.88%2/10/20152/12/20153/6/2015Tweet This Announcement  Share This Announcement on StockTwits
10/17/2014quarterly$0.611.77%11/10/201411/13/201412/5/2014Tweet This Announcement  Share This Announcement on StockTwits
7/25/2014quarterly$0.611.99%8/12/20148/14/20149/5/2014Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014quarterly$0.611.96%5/13/20145/15/20146/6/2014Tweet This Announcement  Share This Announcement on StockTwits
12/13/2013quarterly$0.612.18%2/11/20142/13/20143/7/2014Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013quarterly$0.471.62%11/12/201311/14/201312/6/2013Tweet This Announcement  Share This Announcement on StockTwits
7/26/2013quarterly$0.471.72%8/14/20138/16/20139/6/2013Tweet This Announcement  Share This Announcement on StockTwits
3/6/2013quarterly$0.472.02%5/14/20135/16/20136/7/2013Tweet This Announcement  Share This Announcement on StockTwits
12/13/2012quarterly$0.472.11%2/11/20132/13/20133/7/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Amgen (NASDAQ:AMGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/4/2016Madhavan BalachandranEVPSell30,000$154.12$4,623,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016David BaltimoreDirectorSell3,312$157.21$520,679.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Sean E HarperEVPSell21,875$157.99$3,456,031.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2015Carbonnel Francois DeDirectorSell5,000$153.84$769,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2015Fred HassanDirectorBuy3,010$166.63$501,556.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Cynthia M PattonSVPSell4,530$157.06$711,481.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015Stuart A TrossSVPSell3,012$169.31$509,961.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2015Sean E HarperEVPSell28,000$171.58$4,804,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Stuart A TrossSVPSell4,415$157.74$696,422.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015David BaltimoreDirectorSell3,647$158.76$578,997.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2015Robert A BradwayCEOSell22,000$152.69$3,359,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Frank C HerringerDirectorBuy3,000$152.29$456,870.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2014Carbonnel Francois DeDirectorSell3,000$168.01$504,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Cynthia M PattonSVPSell2,644$127.97$338,352.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Sean E HarperEVPSell14,000$127.29$1,782,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014Thomas J.W. DittrichCAOSell4,130$112.83$465,987.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2014A Kelly MichaelCFOSell2,065$110.45$228,079.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Carbonnel Francois DeDirectorSell1,000$126.69$126,690.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Madhavan BalachandranEVPSell18,000$112.76$2,029,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013David BaltimoreDirectorSell4,582$109.66$502,462.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Thomas J.W. DittrichCAOSell6,130$104.78$642,301.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Madhavan BalachandranEVPSell6,000$103.28$619,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013Rebecca M HendersonDirectorSell8,421$105.72$890,268.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Cynthia M PattonSVPSell3,544$105.01$372,155.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Judith C PelhamDirectorSell25,000$108.25$2,706,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Amgen (NASDAQ:AMGN)
DateHeadline
07/26/16 12:00 PMHC Stocks Growth: Amgen, Inc. (NASDAQ:AMGN), Opko Health Inc. (NASDAQ:OPK) - share market updates (press release)
07/26/16 12:00 PMStocks With Notable Analysts Assessments: Amgen, Inc. (NASDAQ:AMGN), Crown Castle International Corp (NYSE:CCI) - Review Fortune
07/26/16 12:00 PMHave a Glance at Exelixis, Inc. (NASDAQ:EXEL), Amgen, Inc. (NASDAQ:AMGN) - Post Registrar
07/26/16 12:00 PMAmgen, Inc.: AMGN Stock May Be Prepping for a Surge - Investorplace.com
07/25/16 03:00 PMLamond Capital Partners Exits Position in Amgen (AMGN)
07/25/16 09:25 AMAmgen, Inc.: AMGN Stock May Be Prepping for a Surge - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips A breakout, relative strength and bid options premiums point to a bullish earnings reaction in AMGN this week. The post Amgen, Inc.: AMGN Stock May Be Prepping for a Surge appeared first on InvestorPlace.
07/25/16 07:14 AMCarter Worth And Mike Khouw's Amgen Trade - Benzinga
07/25/16 07:14 AMAnalysts Observing Stocks Update: Medtronic plc (NYSE:MDT) , Amgen Inc. (NASDAQ:AMGN) - Street Updates
07/25/16 06:36 AMAmgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain? -
07/23/16 02:27 PMStock Performance Rundown on Amgen Inc. (NASDAQ:AMGN) - Engelwood Daily
07/23/16 06:31 AMFriday Session Wrap-up for Amgen Inc. (NASDAQ:AMGN) - Engelwood Daily
07/22/16 07:29 PMAmgen Inc (NASDAQ:AMGN) in Good Position - Street Report
07/22/16 05:58 PMFourth Straight Week Of Gains; Buckle Up For Earnings -
07/22/16 05:08 PMAmgen Announces Webcast Of 2016 Second Quarter Financial Results - [at noodls] - THOUSAND OAKS, Calif., July 22, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Wednesday, July 27, 2016, after the close of the U.S. ...
07/22/16 05:08 PMAmgen Announces 2016 Third Quarter Dividend - [at noodls] - THOUSAND OAKS, Calif., July 22, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.00 per share dividend for the third quarter of 2016. The dividend will ...
07/22/16 03:12 PMAmgen declares $1.00 dividend -
07/22/16 02:27 PMIntraday Active Biotech Stocks News: Amgen Inc. (NASDAQ:AMGN), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) - The Voice Registrar
07/22/16 02:27 PMHC Stocks News Ring: Amgen, Inc. (NASDAQ:AMGN), Novo Nordisk A/S (ADR) (NYSE:NVO) - share market updates (press release)
07/22/16 12:51 PMAmgen 2Q Earnings: Here's What To Expect -
07/22/16 10:39 AMBaird Isn't Changing Its Outlook On Amgen - Benzinga
07/22/16 10:39 AMPrice Target Update: Amgen Inc. (NASDAQ:AMGN) - News Oracle
07/22/16 08:30 AM7 Great Stocks With Rising Dividends -
07/22/16 01:30 AM2:30 am Amgen and UCB submit Biologics License Application to the FDA for Romosozumab -
07/22/16 01:07 AMBRIEF-Amgen and UCB submit biologics license application for romosozumab to the FDA - * Amgen and UCB submit biologics license application for romosozumab to the FDA
07/21/16 08:02 PMStock Update: Amgen Inc
07/21/16 02:27 PMStock Catching Eyes of Investors: Amgen Inc. (NASDAQ:AMGN) - TGP
07/21/16 02:27 PMHigh Expectations Remain For Amgen Inc. (NASDAQ:AMGN) - TGP
07/21/16 02:27 PMHot Biotech Stocks Recap: Exelixis, Inc. (NASDAQ:EXEL), Amgen Inc. (NASDAQ:AMGN) - The Voice Registrar
07/21/16 10:49 AMAmgen To Pay $95 Mln To Settle Securities Litigation
07/21/16 10:25 AMAmgen (AMGN) Stock Rises on 'Non-Inferior' Late-Stage Trial Results -
07/20/16 07:29 PMAmgen Announces Settlement Of Securities Litigation - [PR Newswire] - THOUSAND OAKS, Calif., July 20, 2016 /PRNewswire/ -- Amgen (AMGN) today announced that it has entered into an agreement with plaintiffs to resolve In re Amgen Inc. Securities Litigation, CV-07-2536 PSG, a previously disclosed securities class action lawsuit pending in the United States District Court for the Central District of California. The settlement class consists of purchasers of Amgen's publicly-traded securities during the period from April 22, 2004, through May 10, 2007, seeking to recover damages under the federal securities laws for certain statements made by Amgen. Under the agreement, Amgen will pay $95 million into a settlement fund to be distributed to class members. The settlement is subject to court approval. Amgen believes the action has no merit, and the settlement does not constitute any admission by Amgen of any liability or wrongdoing. Nonetheless, it is desirable and beneficial to Amgen and its shareholders to resolve the case as further litigation would be burdensome and protracted.
07/20/16 03:32 PMTechnical Coverage on Biotechnology Equities -- Galena Biopharma, Eleven Biotherapeutics, Relypsa, and Amgen
07/20/16 10:35 AMAnalyst's Checklist Stocks: Gilead Sciences, Inc. (NASDAQ:GILD) , Amgen Inc. (NASDAQ:AMGN) - Street Updates
07/20/16 10:35 AMHot Stock seeking Investors: Amgen Inc. (NASDAQ:AMGN) - News Oracle
07/20/16 10:35 AM2 Biotech Stocks News And Price Trends: Amgen Inc. (NASDAQ:AMGN), ImmunoGen, Inc. (NASDAQ:IMGN) - The Voice Registrar
07/20/16 08:47 AMBiotech: As Cheap as They Come -
07/19/16 07:53 PMCompany Update: Amgen Inc (NASDAQ:AMGN) – U.S. FDA knocks back Novartis copy of Amgen’s drug Neulasta
07/19/16 02:27 PMEquity Roundup: Stock Performance Focus on Amgen Inc. (NASDAQ:AMGN) - Press Telegraph
07/19/16 02:27 PMStocks in the Spotlight: Amgen Inc. (AMGN), Hexcel Corp. (HXL), SunPower Corporation (SPWR) - iStreetWire
07/19/16 12:07 PMNovartis Set To Become Biosimilar Pioneer By 2020 -
07/18/16 02:31 PMAnalysts Pounding the Table on Shares of Amgen Inc. (NASDAQ:AMGN) - TGP
07/18/16 02:31 PMHealthcare Stocks to Lookout: Amgen, Inc. (NASDAQ:AMGN), Eli Lilly and Co (NYSE:LLY) - Post Registrar
07/18/16 11:07 AMBiogen: Key Analyst Recommendations in 2016 -
07/18/16 07:19 AMOakbrook Investments LLC Decreased Stake in Amgen INC (NASDAQ:AMGN) by $3.65 Million as Shares Declined - Consumer Eagle
07/18/16 07:19 AMNoteworthy Analyst's Rating to Observe: Endo International plc (NASDAQ:ENDP) , Amgen Inc. (NASDAQ:AMGN) - Street Updates
07/17/16 02:03 PM3 Biotech Stocks for Conservative Investors -
07/17/16 07:12 AMAmgen Inc. (NASDAQ:AMGN) Broker Price Targets For The Coming Week - Fiscal Standard
07/15/16 01:02 PMUpdate on Amgen Inc. (NASDAQ:AMGN) for the day - Twin County News
07/15/16 01:02 PMCurrent Amgen Inc. (NASDAQ:AMGN) PT Means Stock Is Worth Almost $206 - Review Fortune
07/15/16 01:02 PMAmgen Inc Realized Volatility Hits Extremely Low Level - CML News

Social

About Amgen

Amgen logoAmgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. The Company's business segment is human therapeutics. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as Vectibix (panitumumab), Nplate (romiplostim) and Corlanor (ivabradine). The Company focuses its research and development on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience. Its products in Phase III programs include Aranesp for Myelodysplastic syndromes; ENBREL for Psoriatic arthritis and Rheumatoid arthritis remission; IMLYGIC for Metastatic melanoma, and Kyprolis for Multiple myeloma.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AMGN
  • CUSIP: 03116210
Key Metrics:
  • Previous Close: $167.67
  • 50 Day Moving Average: $156.46
  • 200 Day Moving Average: $153.14
  • P/E Ratio: 17.74
  • P/E Growth: 1.76
  • Market Cap: $125.96B
  • Beta: 0.82
  • Current Year EPS Consensus Estimate: $11.18 EPS
  • Next Year EPS Consensus Estimate: $12.04 EPS
Additional Links:
Amgen (NASDAQ:AMGN) Chart for Wednesday, July, 27, 2016